Assessement of Hepcidin in Saliva in Human Volunteers
Detection of Hepcidin in Saliva and Its Utility as a Diagnostic Marker for Iron Deficiency
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland, 8092
- Laboratory of Human Nutrition
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Normal-weight (BMI 18-24.9kg/m2)
- fasting
- Participants Need to have brushed their teeth at least 1 hour before the visit
Exclusion Criteria:
- acute, chronic illness
- use of long-term medication other than contraception
- medical Problems known to affect Fe homeostasis
- smoking
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Saliva hepcidin
Time Frame: Day 1am
|
Day 1am
|
|
|
Serum hepcidin
Time Frame: Day 1am
|
Day 1am
|
|
|
Serum ferritin
Time Frame: Day 1am
|
Iron Status parameter
|
Day 1am
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin
Time Frame: Day 1am
|
Day 1am
|
|
|
Transferrin receptor
Time Frame: Day 1am
|
Iron Status parameter
|
Day 1am
|
|
c-reactive protein
Time Frame: Day 1am
|
Inflammation parameter
|
Day 1am
|
|
alpha-glycoprotein
Time Frame: Day 1am
|
Inflammation parameter
|
Day 1am
|
|
Saliva hepcidin
Time Frame: Day 1pm
|
to assess variability in saliva hepcidin during the day
|
Day 1pm
|
|
Saliva hepcidin
Time Frame: Day 2am
|
to assess variability in saliva hepcidin in two samples measured at the same time of the day
|
Day 2am
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- HepSa
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.